Healthcare can be complicated.
Your cardiology news shouldn’t be.
Join thousands of cardiology leaders today.
Cardiology June 1, 2026
One Microplastic’s Way to Your Heart is Through the Gut June 1, 2026
Most microplastic research usually focuses on tissue build-up, but a new Circulation study suggests Bisphenol F (BPF) damages our heart muscle through an unexpected pathway in the gut.
Cardiology May 28, 2026
The 40 Best Cardiology Resources to Follow in 2026 May 28, 2026
Whether it’s debate about technology, therapy, or ethics, cardiologists are some of the most vocal and passionate members of the medical community, and their opinions can be found across X, LinkedIn, and beyond.
Heart Failure May 21, 2026
Inflammation’s Prevalence and Role in Heart Failure May 21, 2026
Heart failure inflammation might actually be an underrecognized therapeutic target, after results from the POSEIDON registry analysis found that systemic inflammation is present in nearly half of heart failure patients, regardless of ejection fraction.
Structural Heart May 18, 2026
Cardiac Wire’s State of The Transcatheter Valve May 18, 2026
It might feel like a transcatheter alphabet soup out there with all of the valve interventions that have come out in the last few years, but Cardiac Wire is here to help make sense of it all.
More Stories
Structural Heart May 14, 2026
The Young TAVR Trend is Stabilizing May 14, 2026
Despite a TAVR popularity surge in recent years, a Vizient registry analysis suggests the procedure’s prevalence has stabilized in patients under 65, but there’s still significant debate on whether the young patient TAVR rate is appropriate.
Cardiovascular Disease May 11, 2026
BP Lowering Still Decreases CVD Risk Even in CKD May 11, 2026
Data from a new Lancet study suggests that patients with chronic kidney disease (CKD) might get similar cardiovascular protection from blood pressure drugs as the general population, giving physicians some certainty about how to approach BP in these patients.
Cardiology Pharmaceuticals May 7, 2026
Aficamten, ACACIA-HCM, and the Road to the First nHCM Drug May 7, 2026
The question of how to treat non-obstructive hypertrophic cardiomyopathy has long perplexed researchers and pharmaceutical developers alike, but topline results from Cytokinetics’ Phase 3 ACACIA-HCM trial suggest MYQORZO (aficamten) could be the answer.
Cardiovascular Disease May 4, 2026
The True Cause of Sudden Cardiac Death May 4, 2026
It’s not often that a pair of studies completely challenges our assumptions in cardiology, but new data presented at HRS 2026 suggests myocardial infarction might not be […]
Cardiology April 30, 2026
Cardiac Wire’s Top Six of HRS 2026 April 30, 2026
The Heart Rhythm Society's Annual Meeting for 2026 electrified Chicago with talks of the latest EP tech, rhythm management debates, and insights into where remote patient monitoring is headed. Here are Cardiac Wire’s top-six takeaways from electrophysiology’s biggest weekend of the year.
Cardiology Testing April 27, 2026
Better hs-cTnT Assays, Lower Healthcare Burden April 27, 2026
Cardiac troponin assays might be the gold standard for diagnosing a heart attack in the ER, but a new JAMA study suggests the latest generation of tests could significantly reduce false positives and ultimately, health system burden.
Patient Engagement April 23, 2026
Calcium Supplements May Have CV Risks April 23, 2026
While the verdict is still out on whether or not calcium supplements support bone health, new research in JAHA suggests they’re not good for your heart.
Surgeries & Interventions April 20, 2026
A Look Into Real-World TTVR Results April 20, 2026
We’re finally starting to get some real-world data on treating tricuspid regurgitation with transcatheter tricuspid valve replacement (TTVR) and a new TVT registry study suggests TTVR outcomes are even better than previously thought.
Cardiology Business April 16, 2026
Stryker Steps into IVL with AVS Acquisition April 16, 2026
Intravascular lithotripsy is becoming a game of giants after Stryker’s announcement that it will acquire Amplitude Vascular Systems (AVS) for an undisclosed amount to add the company’s IVL system to its peripheral vascular portfolio.
Cardiology Business April 13, 2026
The Cardiologist Shortage and its Consequences April 13, 2026
We all know there’s a growing cardiologist shortage, but American cardiovascular care might hit its breaking point, with a Medicus Healthcare Solutions analysis now projecting that the shortage will only get bigger, and will hit rural communities the hardest.
Controversies April 9, 2026
Conflict of Interest Allegation Leads to Cardiologist’s Termination April 9, 2026
UPMC's structural heart president, Hemal Gada, MD, might have been terminated for whistleblowing, according to a federal lawsuit that alleges retaliatory firing following his reports of conflicts of interest regarding Edwards Lifesciences and alleged racism within UPMC.
Atrial Fibrillation April 6, 2026
CHAMPION-AF: When Noninferiority is Not Enough April 6, 2026
ACC.26 saw an overall drop in research fervor, but one long-awaited study, CHAMPION-AF, spurred a new discussion around the field of left atrial appendage closure and the data we’ve used to justify the procedure.
Cardiology April 2, 2026
The Top Trends of ACC.26 April 2, 2026
Cardiology came back to New Orleans with ACC.26 and amid the magic of “The Big Easy” some more subtle trends emerged, reflecting a maturation of cardiac science and business. Here are Cardiac Wire’s top takeaways from the conference.
Cardiology Policy March 30, 2026
A Plan to Tackle CAD Mortality by 2050 March 30, 2026
Coronary artery disease is the leading cause of cardiovascular death throughout the world, and a Lancet commission just released a new statement about what it will take to significantly reduce CAD deaths by 2050.
Cardiac Imaging March 26, 2026
What Can Fat Around the Heart Tell Us? March 26, 2026
We all know by now that too much body fat isn’t good for your heart, and new research suggests that the fat directly around your heart could play a role in your risk of coronary artery disease (CAD).
Women's Cardiac Health March 23, 2026
The CV Risks of Premature Menopause March 23, 2026
Keeping a close eye on women’s reproductive health could give insights into their future cardiovascular risk after a new JAMA study found that women who experience premature menopause face higher lifetime risk of coronary heart disease (CHD).
Population Health March 19, 2026
Ultraprocessed Foods are Bad for Everyone and Worse for Some March 19, 2026
We already know that what you put in your body is directly related to your overall health, including cardiovascular risk, but a new JACC study suggests your ethnic background could impact just how much damage ultraprocessed foods do to your body.
Population Health March 16, 2026
Where We’ve Been, and Where We’re Going in CV Health March 16, 2026
JACC released its inaugural Cardiovascular Statistics 2026 report covering a wide spectrum of major CV risk factors and conditions, and despite the medical advancements in the last ten years, it’s clear we still have a lot of work left to do.